314 related articles for article (PubMed ID: 3133660)
1. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
Kawakami K; Scheidereit C; Roeder RG
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4700-4. PubMed ID: 3133660
[TBL] [Abstract][Full Text] [Related]
2. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
Cross SL; Halden NF; Lenardo MJ; Leonard WJ
Science; 1989 Apr; 244(4903):466-9. PubMed ID: 2497520
[TBL] [Abstract][Full Text] [Related]
3. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
Currie RA; Roeder RG
Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
[TBL] [Abstract][Full Text] [Related]
4. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements.
Satyamoorthy K; Park K; Atchison ML; Howe CC
Mol Cell Biol; 1993 Nov; 13(11):6621-8. PubMed ID: 8413258
[TBL] [Abstract][Full Text] [Related]
5. Identification and partial purification of a protein binding to the human immunoglobulin kappa enhancer kappa E2 site.
Gimble JM; Flanagan JR; Recker D; Max EE
Nucleic Acids Res; 1988 Jun; 16(11):4967-88. PubMed ID: 2838809
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity.
Lenardo MJ; Kuang A; Gifford A; Baltimore D
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8825-9. PubMed ID: 2848241
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
Park K; Atchison ML
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
[TBL] [Abstract][Full Text] [Related]
8. Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro.
Scheidereit C; Heguy A; Roeder RG
Cell; 1987 Dec; 51(5):783-93. PubMed ID: 3119226
[TBL] [Abstract][Full Text] [Related]
9. Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core.
Meyer KB; Ireland J
Nucleic Acids Res; 1994 May; 22(9):1576-82. PubMed ID: 8202357
[TBL] [Abstract][Full Text] [Related]
10. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
11. Suppression of signals required for activation of transcription factor NF-kappa B in cells constitutively expressing the HTLV-I Tax protein.
Ruben SM; Rosen CA
New Biol; 1990 Oct; 2(10):894-902. PubMed ID: 1964088
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells.
Lindholm PF; Reid RL; Brady JN
J Virol; 1992 Mar; 66(3):1294-302. PubMed ID: 1738191
[TBL] [Abstract][Full Text] [Related]
13. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
Elmaleh N; Matthias P; Schaffner W
Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
[TBL] [Abstract][Full Text] [Related]
14. Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer.
Clark L; Matthews JR; Hay RT
J Virol; 1990 Mar; 64(3):1335-44. PubMed ID: 2406459
[TBL] [Abstract][Full Text] [Related]
15. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
Wu FK; Garcia JA; Harrich D; Gaynor RB
EMBO J; 1988 Jul; 7(7):2117-30. PubMed ID: 3138113
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.
Lowenthal JW; Ballard DW; Böhnlein E; Greene WC
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2331-5. PubMed ID: 2494663
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.
Osborn L; Kunkel S; Nabel GJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2336-40. PubMed ID: 2494664
[TBL] [Abstract][Full Text] [Related]
18. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
Pongubala JM; Nagulapalli S; Klemsz MJ; McKercher SR; Maki RA; Atchison ML
Mol Cell Biol; 1992 Jan; 12(1):368-78. PubMed ID: 1729611
[TBL] [Abstract][Full Text] [Related]
19. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
[TBL] [Abstract][Full Text] [Related]
20. The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription.
Atchison ML; Perry RP
Cell; 1987 Jan; 48(1):121-8. PubMed ID: 3098435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
